Mayer Brown's Antitrust & Competition practice named in Global Competition Review's Top 20
25 January 2008
Mayer Brown LLP, a leading international law firm, announced that it was named by Global Competition Review (GCR) as one of the Top 20 global firms for its Antitrust & Competition practice . Additionally, they selected Lee Abrams, Robert Bloch, Richard Favretto, Andy Marovitz and Richard Steuer as Who's Who nominees; called Don Klawiter's move to Mayer Brown "one of the lateral moves of the year;". The independent survey of the world's leading 100 competition practices takes into account the following five factors: the size of the practice; its standing among its rivals and corporate counsel; the number of Who's Who nominees and the stability of its partnership.
In ranking Mayer Brown, GCR noted "the wide cross-section of cases" handled by the group. They cited the firm's two Supreme Court victories last term; Credit Suisse v Billing in which Mayer Brown attorneys convinced the Court to dismiss actions against the country's largest investment banks and mutual funds, which were accused of entering into illegal contracts with purchasers of securities in more than 900 IPOs during the dot-com market bubble; and Weyerhaeuser Co v Ross-Simmons Hardware, the firm's defense of Weyerhaeuser against allegations of predatory buying resulting in the reversal of $78 million award against the client.
Also noted was Mayer Brown's "landmark victory" for Evanston Northwestern Healthcare Corporation, which had been ordered to unwind its merger with Highland Park Hospital. On appeal the FTC rejected the divestment remedy in a bid to preserve the healthcare improvements.
In addition, the firm represented United Airlines in a national class action case alleging illegal surcharges among global air-cargo carriers, in which United was not named in the consolidated amended complaint, and reached a settlement with the plaintiffs without issuing a cash payment. The ranking also mentioned Mayer Brown's work on behalf of the Chicago Board of Trade in its merger with Chicago Mercantile Exchange, as well as AstraZeneca's acquisition of MedImmune.
Mayer Brown has done significant work for European clients as well, including advising the London Metal Exchange regarding an injunction imposed on its trading activities by the UK Office of Fair Trading; representing Onex/ClienLogig regarding its US and EU filings for the ?450 million acquisition of rival Sitel; and representing Swiss chemical company Lonza with their worldwide filings related to the ?450 million acquisition of the Cambrex Bio Business.
Mayer Brown's Antitrust & Competition practice attorneys are leaders in antitrust and competition law and bring extensive and far-ranging experience and high-quality service to important matters related to mergers, cartel investigations, complex civil litigation, dominance and abusive conduct inquiries and state aid. Our global resources and experience enable us to represent clients in high-stake litigation, including litigation before the US Supreme Court and the European Courts of Justice; and represent clients in criminal and civil investigations. We have substantial experience with all aspects of the Hart-Scott-Rodino process, the EC merger regulation and national regimes in Europe. Our global capacity allows us to manage multi-jurisdictional filings and advise on the applicability of national merger control regulations and to secure merger control clearances throughout the world.